参考文献
［1］Spergel JM，Paller AS.Atopic dermatitis and the atopic march［J］.J Allergy Clin Immunol，2003，112（6）：S118-S127.
［2］Schroeder A，Kumar R，Pongracic JA，et al.Food allergy is associated with an increased risk of asthma［J］.Clin Exp Allergy，2009，39（2）：261-270.
［3］Hill DJ，Hosking CS，de Benedictis FM，et al.Confirmation of the association between high levels of immunoglobulin E food sensitization and eczema in infancy：an international study［J］.Clin Exp Allergy，2008，38（1）：161-168.
［4］Yang L，Fu J，Zhou Y.Research progress in atopic march［J］.Front Immunol，2020，11：1907.
［5］Tam JS.Cutaneous manifestation of food allergy［J］.Immunol Allergy Clin North Am，2017，37（1）：217-231.
［6］Brough HA，Liu AH，Sicherer S，et al.Atopic dermatitis increases the effect of exposure to peanut antigen in dust on peanut sensitization and likely peanut allergy［J］.J Allergy Clin Immunol，2015，135（1）：164-170.
［7］Thyssen JP，Godoy-Gijon E，Elias PM.Ichthyosis vulgaris：the filaggrin mutation disease［J］.Br J Dermatol，2013，168（6）：1155-1166.
［8］van den Oord RA，Sheikh A.Filaggrin gene defects and risk of developing allergic sensitisation and allergic disorders：systematic review and meta-analysis［J］.Bmj，2009，339：b2433.
［9］Hsu JI，Pflugfelder SC，Kim SJ.Ocular complications of atopic dermatitis［J］.Cutis，2019，104（3）：189- 193.
［10］Paller A，Jaworski JC，Simpson EL，et al.Major comorbidities of atopic dermatitis：beyond allergic disorders［J］.Am J Clin Dermatol，2018，19（6）：821-838.
［11］Joo JY，Cho JM，Yoo IH，et al.Eosinophilic gastroenteritis as a cause of non-Helicobacter pylori，non-gastrotoxic drug ulcers in children［J］.BMC Gastroenterol，2020，20（1）：280.
［12］Mohan CG，Silverberg JI.Association of vitiligo and alopecia areata with atopic dermatitis［J］.JAMA Dermatology，2015，151（5）：522-528.
［13］Drucker AM，Thompson JM，Li WQ，et al.Incident alopecia areata and vitiligo in adult women with atopic dermatitis：Nurses'Health Study 2［J］.Allergy，2017，72（5）：831-834.
［14］Givler DN，Basit H，Givler A，et al.Clinical differences between atopic and atopiform dermatitis［J］.J Am Acad Dermatol，2008，58（3）：407-414.
［15］Paller A，Jaworski JC，Simpson EL，et al.Major comorbidities of atopic dermatitis：beyond allergic disorders［J］.American Journal of Clinical Dermatology，2018，19（6）：821-838.
［16］Sparber F，de Gregorio C，Steckholzer S，et al.The skin commensal yeast malassezia triggers a type 17 response that coordinates anti-fungal immunity and exacerbates skin inflammation［J］.Cell Host Microbe，2019，25（3）：389-403.
［17］Otsuka R，Tanaka A，Takahashi M，et al.The relationship between the development of erythroderma in patients with atopic dermatitis and the avoidance of anti-inflammatory topical drugs［J］.Allergol Int，2021，70（3）：376-378.
［18］Candotti F.Clinical manifestations and pathophysiological mechanisms of the Wiskott-Aldrich syndrome［J］.J Clin Immunol，2018，38（1）：13-27.(https://www.daowen.com)
［19］Chiticariu E，Hohl D.Netherton syndrome：insights into pathogenesis and clinical implications［J］.J Invest Dermatol，2020，140（6）：1129-1130.
［20］Ponsford MJ，Klocperk A，Pulvirenti F，et al.Hyper-IgE in the allergy clinic—when is it primary immunodeficiency？［J］.Allergy，2018，73（11）：2122-2136.
［21］Holland SM，DeLeo FR，Elloumi HZ，et al.STAT3 mutations in the hyper-IgE syndrom［J］.N Engl J Med，2007，357（16）：1608-1619.
［22］Poe MD，Chagnon SL，Escolar ML.Early treatment is associated with improved cognition in Hurler syndrome［J］.Ann Neurol，2014，76（5）：747-753.
［23］Rehal B，Armstrong AW.Health outcome measures in atopic dermatitis：a systematic review of trends in disease severity and quality-of-life instruments 1985-2010［J］.PLoS One，2011，6（4）：e17520.
［24］Ho CJH，Yew YW，Dinish US，et al.Handheld confocal Raman spectroscopy（CRS）for objective assessment of skin barrier function and stratification of severity in atopic dermatitis（AD）patients［J］.J Dermatol Sci，2020，98（1）：20-25.
［25］Nakahara T，Izuhara K，Onozuka D，et al.Exploration of biomarkers to predict clinical improvement of atopic dermatitis in patients treated with dupilumab：a study protocol［J］.Medicine（Baltimore），2020，99（38）：e22043.
［26］Breiteneder H，Peng YQ，Agache I，et al.Biomarkers for diagnosis and prediction of therapy responses in allergic diseases and asthma［J］.Allergy，2020，75（12）：3039-3068.
［27］Lewis-Jones MS，Finlay AY.The children's dermatology life quality index（CDLQI）：initial validation and practical use［J］.Br J Dermatol，1995，132（6）：942-949.
［28］Beattie PE，Lewis-Jones MS.An audit of the impact of a consultation with a paediatric dermatology team on quality of life in infants with atopic eczema and their families：further validation of the Infants'Dermatitis Quality of Life Index and Dermatitis Family Impact score［J］.Br J Dermatol，2006，155（6）：1249-1255.
［29］宋志强.特应性皮炎的临床表型和内表型［J］.中华皮肤科杂志，2021，54（3）：259-263.
［30］中华医学会皮肤性病学分会免疫学组，特应性皮炎协作研究中心.中国特应性皮炎诊疗指南（2020版）［J］.中华皮肤科杂志，2020，53（2）：81-88.
［31］Pyun BY.Natural history and risk factors of atopic dermatitis in children［J］.Allergy Asthma Immunol Res，2015，7（2）：101-105.
［32］Davidson WF，Leung DYM，Beck LA，et al.Report from the national institute of allergy and infectious diseases workshop on“atopic dermatitis and the atopic march：mechanisms and interventions”［J］.J Allergy Clin Immunol，2019，143（3）：894-913.
［33］Silvestre Salvador JF，Romero-Pérez D，Encabo-Durán B.Atopic dermatitis in adults：a diagnostic challenge［J］.J Investig Allergol Clin Immunol，2017，27（2）：78-88.
［34］Silverberg JI，Vakharia PP，Chopra R，et al.Phenotypical differences of childhoodand adult-onset atopic dermatitis［J］.J Allergy Clin Immunol Pract，2018，6（4）：1306-1312.
［35］Son JH，Chung BY，Kim HO，et al.Clinical features of atopic dermatitis in adults are different according to onset［J］.J Korean Med Sci，2017，32（8）：1360- 1366.